Amalie K. Bentzen
Kongens Lyngby, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Antigen-scaffolds loaded with hyper-stable neoleukin-2/15 expand antigen-specific T cells with a favorable phenotype for adoptive cell therapy.
Journal: Frontiers in immunology
Published: February 05, 2026
T antigen-specific CD8+ T cells associate with PD-1 blockade response in virus-positive Merkel cell carcinoma.
Journal: The Journal of clinical investigation
Published: October 31, 2023
TCR-engaging scaffolds selectively expand antigen-specific T-cells with a favorable phenotype for adoptive cell therapy.
Journal: Journal for immunotherapy of cancer
Published: July 16, 2023
Clonal driver neoantigen loss under EGFR TKI and immune selection pressures.
Journal: Nature
Published: December 16, 2022
A T cell receptor targeting a recurrent driver mutation in FLT3 mediates elimination of primary human acute myeloid leukemia in vivo.
Journal: Nature cancer
Published: November 16, 2022
Neoantigen-reactive CD8+ T cells affect clinical outcome of adoptive cell therapy with tumor-infiltrating lymphocytes in melanoma.
Journal: The Journal of clinical investigation
Published: May 04, 2021
NetTCR-2.0 enables accurate prediction of TCR-peptide binding by using paired TCRα and β sequence data.
Journal: Communications biology
Published: April 08, 2021
Neoantigen-specific CD8 T cell responses in the peripheral blood following PD-L1 blockade might predict therapy outcome in metastatic urothelial carcinoma.
Journal: Nature communications
Published: January 19, 2021
Human endogenous retroviruses form a reservoir of T cell targets in hematological cancers.
Journal: Nature communications
Published: January 02, 2020
T-cell-receptor cross-recognition and strategies to select safe T-cell receptors for clinical translation.
Journal: Immuno-oncology technology
Published: September 01, 2019
Last Updated: 09/26/2026